epm Therapeutics

epm Therapeutics epm Therapeutics is a biotech company working to develop cannabinoid-acid–based therapies for people living with rare and complex conditions.

Our lead compound, EPM301, aims to improve quality of life for patients with Prader-Willi Syndrome (PWS).

As a new school year begins, having the right resources in place can help families feel more prepared and help school te...
09/03/2026

As a new school year begins, having the right resources in place can help families feel more prepared and help school teams better understand the unique needs of students with Prader-Willi syndrome (PWS).

EmpowerED Solutions offers School Resource Templates designed to help parents and caregivers communicate important information with school personnel, including resources on Health & Nutrition at School and Safety Alerts for School Personnel.

Explore the templates and other PWS resources from Empowered Education Solutions: https://www.facebook.com/empowerededucationsolutions/posts/pfbid0gu7eVfD9YgXAo88eEmVxMdhgryesN1uw4EHSrpwvMc9pA35jxkqXjR6xmbUdtT5nl

🚨NEW PWS SCHOOL RESOURCES🚨

Back-to-school means making sure the people supporting your child have the information they need to keep them safe and supported.

🆕 We’ve added NEW customizable resources to the EmpowerED Solutions website, including:

✨ Canva “All About Me” Templates
Create a personalized, easy-to-read snapshot of your child’s strengths, needs, medical considerations, and helpful support strategies through each stage of their educational journey.

🚌 Transportation Safety Alert
Important information for bus drivers, aides, and transportation staff about food security, temperature regulation, hypotonia, and other PWS-specific safety needs.

⚠️ Health & Food Safety Alert
A quick visual reminder of critical PWS food security precautions for staff. Perfect for substitute folders, emergency information, or as the cover page of an individualized health plan so essential information is immediately visible.

These resources are designed to make it easier for families to share clear, practical information with everyone who supports their child throughout the school day.

💻 Find the new resources at empoweredsolutions.org/resources

What’s next for epm Therapeutics? We have a clear regulatory roadmap for EPM301, a therapy that may address multiple PWS...
08/31/2026

What’s next for epm Therapeutics? We have a clear regulatory roadmap for EPM301, a therapy that may address multiple PWS symptoms by targeting hyperphagia, anxiety, and sleep disturbances, all in an easy-to-administer oral treatment.

The path forward is clear, but we can't do it alone. For families, clinicians, caregivers, advocates and investors who are ready to redefine PWS care, please join us.

Reach us at [email protected].

With back-to-school season in full swing, ensuring educators and school staff understand the unique needs of students li...
08/28/2026

With back-to-school season in full swing, ensuring educators and school staff understand the unique needs of students living with Prader-Willi syndrome (PWS) is an important part of a successful school experience.

Check out this helpful resource from Prader-Willi Syndrome Association UK to learn more about the training options they offer for educators:

We loved seeing Becca and Laz of Raising Lazarus - PWS featured in today’s edition of The Foundation for Prader-Willi Re...
08/26/2026

We loved seeing Becca and Laz of Raising Lazarus - PWS featured in today’s edition of The Foundation for Prader-Willi Research newsletter! 💛 We had the privilege of meeting them at One Small Step KY earlier this month, which is highlighted in the newsletter.

Be sure to follow their inspiring story and learn more about their journey:
Instagram: https://www.instagram.com/raisinglazaruspws/
TikTok: https://www.tiktok.com/

You can also sign up for updates from the Foundation for Prader-Willi Research here: https://bit.ly/FPWR_Newsletter

EPM301, our lead investigational compound, has received an Orphan Drug Designation (ODD) from both the European Medicine...
08/25/2026

EPM301, our lead investigational compound, has received an Orphan Drug Designation (ODD) from both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration.

This designation allows us to accelerate the development of treatments for conditions that often have limited or no approved options, like .

The Orphan Drug Designation helps remove some of the barriers to developing innovative therapies, ultimately bringing potential treatments — like EPM301 — to patients and families faster.

It's back-to-school season! This time can bring a mix of excitement and new challenges for families affected by Prader-W...
08/22/2026

It's back-to-school season! This time can bring a mix of excitement and new challenges for families affected by Prader-Willi syndrome. Check out these helpful tips from Prader-Willi Syndrome Association USA to support students with PWS as they head back to the classroom:

Many families are preparing for a new school year, likely with a mixture of excitement and anxiety. Stacy Ward, PWSA | USA's CEO offers words of encouragement to help ease some anxiety, along with some very helpful tips for families on how to prepare for a successful school year.

Read this letter at https://www.pwsausa.org/back-to-school-tips-for-a-successful-school-year/

Are you attending Prader-Willi Research Foundation Australia's 2026 Prader-Willi Syndrome Research and Family Conference...
08/21/2026

Are you attending Prader-Willi Research Foundation Australia's 2026 Prader-Willi Syndrome Research and Family Conference? epm Therapeutics President & CEO Dr. Peter Welburn will be attending the event and joining the “Research that Leads to Impact” panel.

We hope to see you there!

Team epm is looking forward to attending The Foundation for Prader-Willi Research's Annual Research Symposium and Family...
08/14/2026

Team epm is looking forward to attending The Foundation for Prader-Willi Research's Annual Research Symposium and Family Conference, coming up October 7-10!

If you're planning on attending, make sure to score the early bird discount before prices increase tomorrow. ⬇️

Early Bird Registration ENDS August 15th

Our current registration price of $275 will increase to $325- you don't want to miss this early bird pricing!

Learn more: https://hubs.la/Q04sw93h0

epm Therapeutics is committed to developing EPM301 - a potential breakthrough therapy for Prader-Willi syndrome. Our mis...
08/13/2026

epm Therapeutics is committed to developing EPM301 - a potential breakthrough therapy for Prader-Willi syndrome. Our mission is to deliver a safe and effective treatment that improves quality of life for patients and their families.

EPM301 is a cannabinoid chemically known as cannabidiol acid methyl ester (CAME). CBD acids (CBD-A), like our lead investigational compound EPM301, are pharmacologically distinct compared to CBD.

Slide through the photos below to learn more about Cannabidiol acids and how EPM 301 is being developed it to treat symptoms of ⬇

We had such an impactful and inspiring time attending the One Small Step fundraiser in Elizabethtown, KY this weekend!In...
08/12/2026

We had such an impactful and inspiring time attending the One Small Step fundraiser in Elizabethtown, KY this weekend!

In addition to proudly sponsoring the event, we were honored to stand alongside the community and the The Foundation for Prader-Willi Research as we work toward a brighter future for individuals and families impacted by PWS.

Saturday marked the 4th year of One Small Step Kentucky, and we’re so grateful to everyone who continues to make this event such a success!

HUGE shoutout to our fundraising teams, who raised nearly $7,000 for PWS research: Team Gideon, Tommy, and Lazarus! A special thank you to everyone who rallied around their efforts.

Thank you to our generous sponsors: Soleno Therapeutics, epm Therapeutics, and Harmony Biosciences.

https://hubs.la/Q04ssPc_0

Thank you, Kentucky 🧡

Address

7310 Turfway Road Suite 550
Florence, KY
41042

Alerts

Be the first to know and let us send you an email when epm Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share